Key result
Duchenne Muscular Dystrophy patients had lower left ventricular ejection fraction compared to healthy controls, and those with CMR-documented myocardial inflammation experienced rapid progression to heart failure.
Why the study?
Does myocardial inflammation documented by CMR predict rapid progression to heart failure in patients with Duchenne Muscular Dystrophy?
Cohort (n=40)
No
Does myocardial inflammation documented by CMR predict rapid progression to heart failure in patients with Duchenne Muscular Dystrophy?
Myocardial inflammation detected by CMR in patients with Duchenne Muscular Dystrophy is associated with rapid deterioration of left ventricular function and progression to heart failure.
Answers are grounded in this paper and cite their sources.
CMR-detected myocardial inflammation may flag DMD patients for intensified HF monitoring; leaves open whether anti-inflammatory therapy alters progression.
BACKGROUND: In patients with Duchenne Muscular Dystrophy (DMD), the absent or diminished dystrophin leads to progressive skeletal muscle and heart failure. We evaluated the role of myocardial inflammation as a precipitating factor in the development of heart failure in DMD. METHODS: 20 DMD patients (aged 15-18 yrs) and 20 age-matched healthy volunteers were studied and followed-up for 2 years. Evaluation of myocarditis with cardiovascular magnetic resonance imaging (CMR) was performed using STIR T2-weighted (T2W), T1-weighted (T1W) before and after contrast media and late enhanced images (LGE). Left ventricular volumes and ejection fraction were also calculated. Myocardial biopsy was performed in patients with positive CMR and immunohistologic and polymerase chain reaction (PCR) analysis was employed. RESULTS: In DMD patients, left ventricular end-diastolic volume (LVEDV) was not different compared to controls. Left ventricular end-systolic volume (LVESV) was higher (45.1 +/- 6.6 vs. 37.3 +/- 3.8 ml, p < 0.001) and left ventricular ejection fraction (LVEF) was lower (53.9 +/- 2.1 vs. 63 +/- 2.4%, p < 0.001). T2 heart/skeletal muscle ratio and early T1 ratio values in DMD patients presented no difference compared to controls. LGE areas were identified in six DMD patients. In four of them with CMR evidence of myocarditis, myocardial biopsy was performed. Active myocarditis was identified in one and healing myocarditis in three using immunohistology. All six patients with CMR evidence of myocarditis had a rapid deterioration of left ventricular function during the next year. CONCLUSIONS: DMD patients with myocardial inflammation documented by CMR had a rigorous progression to heart failure.
No takes yet. Share an insight, caveat, or question.
Mavrogeni et al. (2010) conducted a cohort in Duchenne Muscular Dystrophy (n=40). Duchenne Muscular Dystrophy vs. Healthy volunteers was evaluated on Left ventricular ejection fraction (LVEF) (p=<0.001). Duchenne Muscular Dystrophy patients had lower left ventricular ejection fraction compared to healthy controls, and those with CMR-documented myocardial inflammation experienced rapid progression to heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: